Dunning dissections, n (%) |
Type I |
3 (38) |
Type II |
1 (13) |
Type III |
4 (50) |
Revascularized vessel, n (%) |
Left main trunk (LMT) and Left anterior descending (LAD) |
1 (13) |
Right coronary artery (RCA) |
7 (88) |
Multivessel disease |
8 (100) |
Chronic total occlusion CTO) |
3 (38) |
Arterial access, n (%) |
6 F |
7 (88) |
7 F |
1 (13) |
Radial |
1 (13) |
Brachiala
|
2 (25) |
Femorala
|
6 (75) |
Antithrombotic treatment, n (%) |
Acetylsalicylacid |
8 (100) |
Heparin |
8 (100) |
Clopidogrel |
6 (75) |
Prasugrel |
2 (25) |
Abciximab |
2 (25) |
Vitamin K antagonists |
2 (25) |
Non compliant (NC) balloon, n (%) |
3 (38) |
Procedural data, median (IQR) |
Maximum dilation pressure (atm) |
18.0 (17.0–20.0) |
Maximum balloon diameter (mm) |
3.0 (3.0–3.5) |
Maximum balloon length (mm) |
15.0 (15.0–16.3) |
Total stent length (mm) |
30.5 (24.8–59.5) |
Coronary angiography data, median (IQR) |
Procedure time (min) |
80.5 (63.5–108.3) |
Total fluoroscopy time (min) |
19.4 (12.6–30.3) |
Total contrast volume (ml) |
255.0 (158.5–341.3) |
Total radiation exposure (Gycm2) |
62.0 (42.3–177.3) |
CT-data, median (IQR) |
Radiation-Dose (mSV) |
1.9 (1.7–2.0) |
Dose length product (mGy x cm) |
133.2 (121.0–142.3) |
Total contrast volume (ml) |
90 (90.0–90.0) |